We are live on ! Find out more
TCM

Telos Capital Management Portfolio holdings

AUM $1.13B
1-Year Est. Return 27.95%
This Fund
S&P 500
This Quarter Est. Return
+7.36%
1 Year Est. Return
+27.95%
3 Year Est. Return
+71.08%
5 Year Est. Return
+79.02%
10 Year Est. Return
+288.22%
AUM
$982M
AUM Growth
+$64.4M
Cap. Flow
+$11.3M
Cap. Flow %
1.15%
Top 10 Hldgs %
26.7%
Holding
201
New
10
Increased
122
Reduced
55
Closed
5

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$7.74M
2
ZTS icon
Zoetis
ZTS
+$4.87M
3
WM icon
Waste Management
WM
+$1.17M
4
AMTM
Amentum Holdings
AMTM
+$741K
5
TROW icon
T. Rowe Price
TROW
+$668K

Sector Composition

Rank Sector Weight
1 Technology 18.8%
2 Financials 13.74%
3 Industrials 10.88%
4 Healthcare 8.36%
5 Consumer Discretionary 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EW icon
76
Edwards Lifesciences
EW
$51.6B
$4.88M 0.5%
62,415
+7,156
+13% +$534K
AVDV icon
77
Avantis International Small Cap Value ETF
AVDV
$19.3B
$4.23M 0.43%
53,355
+1,580
+3% +$117K
ABT icon
78
Abbott
ABT
$183B
$4.16M 0.42%
30,600
+144
+0.5% +$19K
AVUV icon
79
Avantis US Small Cap Value ETF
AVUV
$31.3B
$3.92M 0.4%
42,992
+3,724
+9% +$321K
EFV icon
80
iShares MSCI EAFE Value ETF
EFV
$29.2B
$3.91M 0.4%
61,569
+1,211
+2% +$74.1K
ABBV icon
81
AbbVie
ABBV
$431B
$3.69M 0.38%
19,876
-337
-2% -$62.6K
IVE icon
82
iShares S&P 500 Value ETF
IVE
$49.8B
$3.61M 0.37%
18,491
+1,504
+9% +$280K
ADBE icon
83
Adobe
ADBE
$102B
$3.55M 0.36%
9,171
-647
-7% -$249K
RSP icon
84
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$3.54M 0.36%
19,502
+1,417
+8% +$245K
WM icon
85
Waste Management
WM
$90B
$3.54M 0.36%
15,449
-5,030
-25% -$1.17M
NVS icon
86
Novartis
NVS
$291B
$3.23M 0.33%
26,690
-748
-3% -$84.3K
XLF icon
87
State Street Financial Select Sector SPDR ETF
XLF
$58.5B
$3.12M 0.32%
59,562
+7,616
+15% +$377K
XOM icon
88
ExxonMobil
XOM
$638B
$3.09M 0.31%
28,696
+835
+3% +$89.3K
SMH icon
89
VanEck Semiconductor ETF
SMH
$72.3B
$3.02M 0.31%
+10,813
New +$2.51M
VXF icon
90
Vanguard Extended Market ETF
VXF
$31.5B
$2.9M 0.3%
15,066
+1,194
+9% +$212K
LLY icon
91
Eli Lilly
LLY
$997B
$2.56M 0.26%
3,280
+1,298
+65% +$1.01M
ACN icon
92
Accenture
ACN
$104B
$2.55M 0.26%
8,546
+788
+10% +$240K
IWS icon
93
iShares Russell Mid-Cap Value ETF
IWS
$16B
$2.5M 0.25%
18,906
+921
+5% +$116K
VBR icon
94
Vanguard Morningstar Small-Cap Value ETF
VBR
$38.1B
$2.31M 0.23%
11,831
+975
+9% +$180K
IBM icon
95
IBM
IBM
$222B
$2.3M 0.23%
7,794
-52
-0.7% -$13.4K
ZTS icon
96
Zoetis
ZTS
$31.9B
$2.01M 0.2%
12,867
-30,695
-70% -$4.87M
UNP icon
97
Union Pacific
UNP
$176B
$1.93M 0.2%
8,389
-77
-0.9% -$17.1K
DE icon
98
Deere & Co
DE
$167B
$1.74M 0.18%
3,416
+25
+0.7% +$12.2K
PLD icon
99
Prologis
PLD
$130B
$1.54M 0.16%
14,653
+5,593
+62% +$587K
TSLA icon
100
Tesla
TSLA
$1.29T
$1.52M 0.15%
4,778
+68
+1% +$20.5K

Similar funds

Telos Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Telos Capital Management held 201 positions worth $982M, up 7% from $918M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Telos Capital Management's Q2 2025 filing shows 10 new, 122 increased, 55 reduced and 5 closed positions. Its largest new stake was VanEck Semiconductor ETF: 10,813 shares worth $3.02M. The largest sale was UnitedHealth, an estimated $7.74M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.

  • Telos Capital Management's largest Q2 2025 buy was VanEck Semiconductor ETF: 10,813 shares worth $3.02M.
  • Telos Capital Management added most to Carrier Global in Q2 2025, an estimated $4.15M increase.
  • Telos Capital Management's biggest Q2 2025 reduction was Zoetis, cutting an estimated $4.87M.
  • Telos Capital Management fully exited UnitedHealth in Q2 2025, selling an estimated $7.74M.
  • Telos Capital Management's ten largest holdings make up 27% of its $982M portfolio in Q2 2025.
  • Telos Capital Management opened 10 new positions and closed 5 in Q2 2025.
  • Telos Capital Management's portfolio value rose 7% quarter-over-quarter to $982M.

Based on Telos Capital Management's 13F filing for Q2 2025, filed 5 Aug 2025.